Trademark: 76355454
Status Date
Friday, December 21, 2012
Registration Number
3093511
Registration Date
Tuesday, May 16, 2006
Filing Date
Friday, January 4, 2002
Published for Opposition
Tuesday, September 24, 2002
Cancellation Date
Friday, December 21, 2012
1 Humanized monoclonal antibody against respiratory syncytial virus for scientific research use
5 Humanized monoclonal antibody against respiratory syncytial virus for medical clinical use
Dec 21, 2012
Cancelled Sec. 8 (6-Yr)
Aug 6, 2008
Automatic Update Of Assignment Of Ownership
Mar 27, 2008
Attorney Revoked And/Or Appointed
Mar 27, 2008
Teas Revoke/Appoint Attorney Received
Sep 1, 2006
Review Of Correspondence Complete
Aug 21, 2006
Paper Received
May 16, 2006
Registered-Principal Register
Apr 4, 2006
Law Office Registration Review Completed
Mar 31, 2006
Assigned To Lie
Mar 17, 2006
Allowed Principal Register - Sou Accepted
Feb 28, 2006
Amendment From Applicant Entered
Feb 7, 2006
Correspondence Received In Law Office
Feb 7, 2006
Paper Received
Feb 17, 2006
Assigned To Examiner
Oct 21, 2005
Paper Received
May 12, 2005
Non-Final Action Mailed
May 11, 2005
Su - Non-Final Action - Written
May 11, 2005
Statement Of Use Processing Complete
May 11, 2005
Extension 3 Granted
Apr 26, 2005
Use Amendment Filed
Apr 26, 2005
Extension 3 Filed
Apr 26, 2005
Teas Extension Received
Apr 26, 2005
Teas Statement Of Use Received
Sep 30, 2004
Extension 2 Granted
Sep 22, 2004
Extension 2 Filed
Sep 22, 2004
Teas Extension Received
Jun 24, 2004
Paper Received
May 5, 2004
Extension 1 Granted
Apr 22, 2004
Extension 1 Filed
May 3, 2004
Case File In Ticrs
Apr 22, 2004
Paper Received
Oct 28, 2003
Noa Mailed - Sou Required From Applicant
Sep 24, 2002
Published For Opposition
Sep 4, 2002
Notice Of Publication
Jun 20, 2002
Approved For Pub - Principal Register
Apr 30, 2002
Correspondence Received In Law Office
Apr 30, 2002
Paper Received
Apr 4, 2002
Non-Final Action Mailed
Mar 28, 2002
Assigned To Examiner
Mar 22, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
